Patents by Inventor Min Guan

Min Guan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220402798
    Abstract: A large-flow precious metal channel is provided, which comprises a molten glass mixed-flow stirring section, at least two molten glass heating, clarifying and cooling sections are connected in parallel at one end of the molten glass mixed-flow stirring section, the other end of which is communicated with a liquid supply tank. The channel is mainly used for the clarification and homogenization of large-flow high-temperature molten glass in the production process of 8.5-generation and higher-generation TFT glass, and provides bubble-free and streak-free high-quality molten glass for subsequent float forming or overflow forming processes.
    Type: Application
    Filed: April 19, 2021
    Publication date: December 22, 2022
    Inventors: Shou Peng, Chong Zhang, Yang Jiang, Liangmao Jin, Zhiqiang Cao, Longyue Jiang, Min Guan, Mingliu Zhu, Yuguo Shen
  • Patent number: 10423725
    Abstract: An intention acquisition method, an electronic device and a computer-readable computer storage are provided.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: September 24, 2019
    Assignee: Ping An Technology (Shenzhen) Co., Ltd.
    Inventors: Junkun Zhou, Min Guan, Jianghao Yan, Xiaoming Peng
  • Publication number: 20190228069
    Abstract: An intention acquisition method, an electronic device and a computer-readable computer storage are provided.
    Type: Application
    Filed: August 31, 2017
    Publication date: July 25, 2019
    Inventors: Junkun Zhou, Min Guan, Jianghao Yan, Xiaoming Peng
  • Patent number: 7850957
    Abstract: The present invention relates to a genic expression adenoviral hybrid vector characterized in that it contains at least the following elements, oriented in the direction 5? to 3?: i. a first chain of adenoviral origin comprising a first inverted terminal repeat (ITR) sequence and a signal sequence for packaging of the adenovirus; ii. a first non-encoding stuffer sequence; iii. a sequence corresponding to a tissue specific promoter; iv. a chain of cDNA derived from an alphavirus, the sequence of which is partly complementary to an alphaviral RNA sequence, comprising at least a sequence encoding for at least one exogenous gene of interest; v. a polyadenylation sequence; and vi.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: December 14, 2010
    Assignee: Proyecto De Biomecdicina Cima, S.L.
    Inventors: Cheng Qian, Min Guan, Cristian Smerdou Picazo, Jesús Prieto Valtueña
  • Patent number: 7695751
    Abstract: The present invention relates to a detoxifizyme with the activity of transforming aflatoxin and the gene encodes thereof. Firstly a novel protein is isolated and purified, named aflatoxin-detoxifizyme (ADTZ), which has the activity of transforming aflatoxin. The ADTZ gene is obtained through specific primers, and the gene is purified and sequenced. The gene encoding of ADTZ is cloned from the total RNA of Armillariella tabescens. The recombinant protein is expressed and purified through various expression systems using genetic engineering methods. The said detoxifizyme has bioactivity of transforming AFB1, reducing mutagenic effects of AFB1. It has great potential for the manufacturing of feed or food and development of anti-tumor medicament.
    Type: Grant
    Filed: January 13, 2005
    Date of Patent: April 13, 2010
    Assignee: Guangzhou Co-Win Bioengineering Co., Ltd.
    Inventors: Dongsheng Yao, Daling Liu, Min Guan, Chunfang Xie
  • Publication number: 20080260711
    Abstract: The present invention relates to a detoxifizyme with the activity of transforming aflatoxin and the gene encodes thereof. Inventors firstly isolate and purify a novel protein, named aflatoxin-detoxifizyme (ADTZ), which has the activity of transforming aflatoxin. The primes specify to the ADTZ gene are obtained through purification and sequencing. The gene encoding of ADTZ is cloned from the total RNA of Armillariella tabescens. The recombinant protein is expressed and purified through various expression systems using genetic engineering methods. The said detoxifizyme has bioactivity of transforming AFB1, reducing mutagenic effects of AFB1. It has great potential for the manufacturing of feed or food and development of anti-tumor medicament.
    Type: Application
    Filed: January 13, 2005
    Publication date: October 23, 2008
    Inventors: Dongsheng Yao, Daling Liu, Min Guan, Chunfang Xie
  • Publication number: 20070224170
    Abstract: The present invention relates to a genic expression adenoviral hybrid vector characterized in that it contains at least the following elements, oriented in the direction 5? to 3?: i. a first chain of adenoviral origin comprising a first inverted terminal repeat (ITR) sequence and a signal sequence for packaging of the adenovirus; ii. a first non-encoding stuffer sequence; iii. a sequence corresponding to a tissue specific promoter; iv. a chain of cDNA derived from an alphavirus, the sequence of which is partly complementary to an alphaviral RNA sequence, comprising at least a sequence encoding for at least one exogenous gene of interest; v. a polyadenylation sequence; and vi.
    Type: Application
    Filed: May 18, 2005
    Publication date: September 27, 2007
    Inventors: Cheng Qian, Min Guan, Cristian Picazo, Jesus Valtuena